Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: CSPC Megalith Biopharmaceutical Co. Ltd.
April 24, 2026
CSPC Megalith Biopharmaceutical Co. Ltd.
Orphan Drug Designation
treatment of small cell lung cancer
Disease Area:
Rare Diseases
Source
Scroll to Top